Obesity affects a large share of the United States population, but a useful academic discussion must avoid treating it as a simple failure of willpower. Current evidence describes obesity as a chronic, multifactorial condition influenced by genetics, neuroendocrine regulation, food environment, sleep, stress, medications, social conditions, physical activity, healthcare access, and many other factors. National data released in 2026 show that 40.3 percent of U.S. adults age 20 and older had obesity during August 2021–August 2023, including 9.7 percent with severe obesity (Fryar, Afful, & Saif, 2026). These figures demonstrate why individual advice alone cannot explain or address the problem.
At the same time, prevalence statistics should not be used to reduce people to body size. Obesity is associated with higher risk of type 2 diabetes, cardiovascular disease, sleep apnea, osteoarthritis, liver disease, some cancers, and other conditions, but risk varies substantially among individuals. A 2025 international commission in The Lancet Diabetes & Endocrinology argued that BMI alone can both overestimate and underestimate disease because it does not directly measure excess adiposity or organ dysfunction (Rubino et al., 2025). This newer framework is useful because it separates a population screening measure from an individual clinical diagnosis.
Obesity Is Better Understood Through Risk, Function, and Context
Body mass index remains widely used because it is inexpensive and practical. In adults, BMI is calculated as weight in kilograms divided by height in meters squared, and a BMI of 30 or higher is conventionally categorized as obesity. In children and adolescents, BMI is interpreted relative to age- and sex-specific growth references. These thresholds are valuable for surveillance and initial screening, but they cannot tell a clinician how much visceral fat a person has, whether the person has metabolic dysfunction, how much muscle is present, or whether mobility and organ function are impaired.
The 2025 Lancet Commission proposed distinguishing excess adiposity from clinical obesity, which it defines through evidence that excess adiposity is causing tissue or organ dysfunction or meaningful limitations in daily activities. This does not eliminate BMI; it places BMI within a broader assessment that may include waist measures, body composition, medical history, laboratory findings, physical function, and comorbidities. The approach also reduces the tendency to assume that everyone in the same BMI category has identical health needs.
Biology contributes strongly to weight regulation. Appetite and satiety are influenced by the brain, gut hormones, adipose tissue, insulin signaling, genetics, sleep, stress, and previous weight loss. When a person loses weight, compensatory changes can increase hunger and reduce energy expenditure, making long-term maintenance difficult. Some endocrine disorders, including Cushing syndrome, can contribute to weight gain, as can selected medications used for psychiatric illness, diabetes, seizures, inflammation, and other conditions. These mechanisms help explain why identical dietary advice produces different outcomes among individuals.
Behavior still matters, but behavior occurs inside an environment. Food prices, work schedules, transportation, school meals, neighborhood safety, disability access, marketing, cooking facilities, family responsibilities, and availability of healthcare all influence what choices are realistic. Food insecurity can coexist with obesity because households may rely on low-cost energy-dense foods or experience cycles of scarcity and availability. Telling a family to “buy healthier food” does little if nutritious options are unaffordable or inaccessible.
The Health Burden Is Real, but Stigma Creates Additional Harm
Obesity is associated with important medical risks. Excess adiposity can contribute to insulin resistance, type 2 diabetes, high blood pressure, dyslipidemia, cardiovascular disease, obstructive sleep apnea, metabolic dysfunction-associated steatotic liver disease, osteoarthritis, kidney disease, reproductive complications, and several cancers (National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2025). Risk increases with factors such as duration of obesity, visceral fat distribution, age, smoking, family history, physical fitness, and coexisting disease.
These associations justify prevention and treatment, but they do not justify stigma. Weight bias appears in schools, workplaces, media, families, and healthcare. People with larger bodies may be stereotyped as lazy, undisciplined, unintelligent, or personally responsible for every health problem they experience. Such assumptions are scientifically weak and can discourage people from seeking medical care.
Healthcare environments can worsen the problem when clinicians attribute unrelated symptoms to weight, use humiliating language, or lack appropriately sized blood-pressure cuffs, gowns, tables, and imaging equipment. Bannuru and colleagues (2025) emphasize that weight stigma can itself become a barrier to effective care. Respectful practice means asking permission before discussing weight, using person-first or patient-preferred language, evaluating symptoms fully, and making treatment decisions collaboratively.
Children and adolescents are particularly vulnerable to the psychological effects of weight stigma. Teasing and bullying may contribute to school avoidance, social isolation, disordered eating, depression, and reduced participation in physical activity. The American Academy of Pediatrics therefore frames pediatric obesity as a chronic, treatable condition requiring family-centered, nonstigmatizing care rather than public weigh-ins, shame-based programs, or restrictive dieting without clinical supervision (Hampl et al., 2023).
Prevention Requires Changes at More Than One Level
Population prevention is most effective when healthy behavior becomes easier rather than when individuals are repeatedly told to make better choices under unchanged conditions. Schools can provide nutritious meals, drinking water, physical education, recess, and protection from bullying. Communities can improve sidewalks, parks, public transportation, disability access, and safe recreation. Healthcare systems can identify risk earlier and provide nutrition, behavioral, sleep, and medical support before severe complications develop.
Food environments also matter. Highly processed products are widely available, convenient, and heavily marketed, while healthier foods may cost more or require more preparation. Policy can influence school-food standards, labeling, marketing to children, food security programs, and retail access. Such interventions should be evaluated carefully because poorly designed taxes or restrictions can place disproportionate burdens on low-income households.
Physical activity should be treated as a health behavior rather than punishment for eating. Walking, swimming, cycling, resistance training, adaptive sports, dancing, and active play can improve cardiovascular health, glucose regulation, strength, mood, sleep, and mobility even when weight loss is modest. A narrow focus on the scale can obscure these benefits and discourage people whose health improves without dramatic weight change.
Sleep and mental health belong in the same prevention framework. Short sleep can affect appetite, stress regulation, and energy. Depression, anxiety, trauma, binge-eating disorder, and chronic stress can interact with eating and activity patterns. Effective programs therefore need to recognize that nutrition and exercise are only part of the clinical and social context.
For children, the U.S. Preventive Services Task Force recommends that clinicians provide or refer children and adolescents age six years or older with a BMI at or above the 95th percentile to comprehensive, intensive behavioral interventions. The 2024 recommendation notes that programs with at least 26 contact hours produced the clearest benefit and generally combined family involvement, nutrition, physical activity, goal-setting, monitoring, and problem solving (USPSTF, 2024). The emphasis is on structured support, not blame.
Treatment Should Be Matched to Disease Severity and Patient Goals
Obesity treatment is increasingly recognized as chronic disease management rather than a short-term diet. Behavioral treatment can include nutrition counseling, self-monitoring, problem solving, sleep improvement, physical activity, stress management, and regular clinical follow-up. Some people respond strongly to these interventions, while others experience limited weight change despite substantial effort.
Prescription medications are evidence-based options for selected adults and adolescents who meet clinical criteria. Modern anti-obesity medications act through different appetite, satiety, metabolic, or gastrointestinal pathways and can produce clinically meaningful weight loss for some patients. Benefits must be weighed against adverse effects, contraindications, cost, access, pregnancy considerations, and the likelihood that treatment may need to continue long term. Medication should not be framed as cheating or as a cosmetic shortcut.
Metabolic and bariatric surgery is another treatment option for appropriately selected patients, particularly those with severe obesity or major obesity-related disease. Surgery can produce large and durable improvements in weight and metabolic outcomes, but it requires informed consent, multidisciplinary evaluation, nutritional follow-up, and long-term monitoring. It is neither appropriate for everyone nor evidence of personal failure.
Treatment goals should extend beyond BMI. Blood pressure, glucose, sleep apnea, liver function, mobility, pain, cardiovascular fitness, mental health, participation, and quality of life may all improve even when a person does not reach a culturally idealized body size. In children who are still growing, preventing additional unhealthy weight gain while improving metabolic health may be clinically meaningful.
The newer clinical-obesity framework strengthens this individualized approach. A person with excess adiposity but no current organ dysfunction may require prevention and monitoring, while a person whose adiposity is already impairing function may need more intensive treatment. This is more informative than assuming that every person above one BMI threshold should receive the same intervention.
American Obesity Policy Must Combine Health Promotion With Respect
Obesity policy often fails when it chooses between two extremes: minimizing health risks to avoid stigma, or emphasizing risk so aggressively that people are shamed. A responsible public-health approach can reject both positions. Obesity is associated with serious disease and deserves prevention and treatment. People with obesity also deserve respectful care, equal opportunity, and freedom from discrimination regardless of whether they lose weight.
The United States therefore needs action at several levels. Individuals need access to evidence-based care and useful health information. Families need affordable food, safe environments, time, and support. Schools and employers should promote health without humiliating people. Healthcare systems need chronic-disease treatment pathways and staff trained to reduce bias. Government and industry influence food pricing, marketing, urban design, insurance coverage, transport, and recreational infrastructure and therefore share responsibility for the environment in which behavior occurs.
Success should be measured by more than national BMI averages. Better indicators include fewer cases of diabetes and cardiovascular disease, improved blood pressure and metabolic markers, better mobility, reduced stigma, improved childhood wellbeing, equitable access to treatment, and healthier environments across income and geographic groups. A public-health strategy that lowers weight while increasing discrimination would be incomplete, just as an anti-stigma strategy that ignores preventable disease would be incomplete.
Obesity in American society is best understood as a chronic and multifactorial health issue embedded in biological, social, and environmental systems. The current evidence supports prevention, intensive behavioral intervention when indicated, medication or surgery for selected patients, and a broader clinical assessment than BMI alone. It also supports a basic ethical principle: health risk should never be confused with human worth. Effective policy reduces disease while preserving dignity.
References
Bannuru, R. R., et al. (2025). Weight stigma and bias: Standards of care in overweight and obesity—2025. BMJ Open Diabetes Research & Care, 13(3), e004962.
Fryar, C. D., Afful, J., & Saif, N. T. (2026). Prevalence of overweight, obesity, and severe obesity among adults age 20 and older: United States, 1960–1962 through August 2021–August 2023. National Center for Health Statistics.
Hampl, S. E., et al. (2023). Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics, 151(2), e2022060640.
Rubino, F., Cummings, D. E., Eckel, R. H., et al. (2025). Definition and diagnostic criteria of clinical obesity. The Lancet Diabetes & Endocrinology, 13(3), 221–262. https://doi.org/10.1016/S2213-8587(24)00316-4
U.S. Preventive Services Task Force. (2024). High Body Mass Index in Children and Adolescents: Interventions.
National Institute of Diabetes and Digestive and Kidney Diseases. (2025). Health Risks of Overweight and Obesity.
Academic Master Education Team is a group of academic editors and subject specialists responsible for producing structured, research-backed essays across multiple disciplines. Each article is developed following Academic Master’s Editorial Policy and supported by credible academic references. The team ensures clarity, citation accuracy, and adherence to ethical academic writing standards
Content reviewed under Academic Master Editorial Policy.
